ETII EnviroTechnologies International Inc (CE)

Healthnostics, Inc. (PINKSHEETS: HNSS) -- As the approaching adoption of SEC rules allowing the Crowdfunding Exemption in the JOBS Act nears, Healthnostics is pleased to announce it is proceeding with preparations for the HNS Crowdfunding Platform. In conjunction with the social media and web-based marketing talent at Noobis, Inc., an InternetArray, Inc. (PINKSHEETS: INAR) holding company, the project is being developed by collaboratively utilizing the unique blend of social media, finance, and internet marketing skills from the two companies. This is the first collaborative project between these companies since the successful Special Distribution by Healthnostics of one share of InternetArray for every three shares owned by Healthnostics shareholders.

Crowdfunding in this context is primarily an Internet instrument that will give entrepreneurs the ability to raise $1 million directly from the public by streamlining the current SEC reporting and filing requirements. This will be a boon to small business capital formation, and Healthnostics, Inc. is unusually positioned to play a significant role in the process through its HNS Fund Co. division.

Upon fulfilling the SEC requirements for Crowdfunding Exemption participation, HNS Crowdfunding will be prepared to offer entrepreneurs immediate access to capital markets. HNS Fund Co. has the expertise in all aspects of this business, being intimately acquainted with small public business regulations, needs, means, structure, and markets.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact: Healthnostics, Inc. Investor Relations P. 917-387-4410 Email Contact